The results of the scientific "complicity" of two Holguín women have begun to cross provincial borders. The idea for the project arose in January 2020, when one of them was struck by the COVID-19 figures reported in China.
Cuba is producing an 18F-fluorodeoxyglucose (18F-FDG) molecule, a radiopharmaceutical that stands out for its effectiveness in detecting tumors and other diseases.
The Biotechnological and Pharmaceutical Industries Group (BioCubaFarma) signed a new cooperation agreement with Chinese joint venture Changheber for the introduction of innovative immunotherapy for the treatment of cancer in the Asian country, it announced via Twitter.
The scientific magazine Vaccines highlighted that an article on Cuba's therapeutic vaccine, known as Nasvac, against hepatitis B today has a great impact internationally.